https://www.selleckchem.com/pr....oducts/dihydroethidi
People who inject drugs are at an increased risk for contracting SARS-CoV-2 and have experienced barriers to accessing harm reduction services during the COVID-19 pandemic. Understanding how to best provide these services is essential for COVID-19 mitigation. The goal of this study was to ascertain challenges and successes for caring for people who inject drugs in Kenya during the COVID-19 pandemic. We conducted focus group discussions and one-on-one key informant interviews with healthcare providers who work with people who inj
Aimer
Commentaire
Partagez
